The Facts on Homozygous Familial Hypercholesterolemia By The FH Foundation
July 24, 2013
Homozygous Familial Hypercholesterolemia - HoFH
What if you had high cholesterol but diet, exercise and commonly used medications couldn’t lower your cholesterol to a recommended level? This frightening condition is real. It’s called HoFH or Homozygous Familial Hypercholesterolemia, and people inherit it from both of their parents. Watch this “Behind the Mystery: Rare and Genetic Diseases” segment as we talk with Dr. Pamela Morris, Cardiologist, Amanda, a 20 year old patient, and Katherine Wilemon from the FH Foundation about the signs, symptoms and what everyone should know about this condition – including that there are treatment options that have been approved in the last year for adults with this disorder.
Supported by Aegerion Pharmaceuticals
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.